Charles Schwab
IMI

Charles Schwab’s Intermolecular, Inc. IMI Stock Holding History

Charles Schwab’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-14,246
Closed -$34K – 3086
2014
Q2 		$34K Sell
14,246
-51,288
-78% -$128K ﹤0.01% 3072
2014
Q1 		$184K Buy
65,534
+33,080
+102% +$120K ﹤0.01% 2966
2013
Q4 		$160K Buy
32,454
+1,296
+4% +$7.32K ﹤0.01% 3005
2013
Q3 		$174K Buy
31,158
+1,746
+6% +$11K ﹤0.01% 2958
2013
Q2 		$213K Buy
+29,412
New +$250K ﹤0.01% 2869

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Charles Schwab's IMI Position: Q3 2014 in Review

Charles Schwab sold out of Intermolecular, Inc. (IMI) in Q3 2014, closing a stake of 14,246 shares — an estimated $34K sold.

Charles Schwab first reported a position in IMI in Q2 2013 and held it in 5 quarters. The position peaked at $213K in Q2 2013. 33 funds tracked by Wall St. Rank hold IMI as of Q3 2014.

  • Charles Schwab reported no remaining Intermolecular, Inc. position as of Q3 2014 after selling out during the quarter.
  • Charles Schwab sold 14,246 Intermolecular, Inc. shares in Q3 2014, an estimated $34K.
  • Charles Schwab first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 5 quarters.
  • Charles Schwab's Intermolecular, Inc. position peaked at $213K in Q2 2013.
  • 33 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2014.

Based on Charles Schwab's 13F filing for Q3 2014, filed 10 Nov 2014.